Note: Ingredients listed on restricted chemical lists
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
<0.05
EC/CAS
220-239-6/2682-20-4
Name of the chemical
2-Methyl-2H-isothiazol-3-one
Concentration
<0.0015
EC/CAS
911-418-6/55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
<0.0015
General Information
Version
1.0
Revision date
2023-10-13
Product name
Newmor Primer Sealer
1.2.1 Relevant identified uses
Multi-Purpose Adhesive And Use As Primer Or Sealer
1.2.2. Uses advised against
any other purpose than stated above
Emergency telephone
+44 (0)1938 552 671
Icons in SDS
Company Information
company name
Newmor Limited
e-mail address of the competent person responsible for the Safety Data Sheet
sales@newmor.com
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Precautionary statements
P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P103 - Read carefully and follow all instructions.
Supplemental label elements
EUH208 - Contains 1,2-benzisothiazol-3(2H)-one, reaction mass of 5-chloro-2-methyl-2H- isothiazol-3-one and 2-methyl-2H-isothiazol-3-one (3:1), 2-methylisothiazol-3(2H)-one. May produce an allergic reaction. EUH210 - Safety data sheet available on request. Extra Labelling Phrases : Contains biocidal products/preservatives to control microbial deterioration: 1,2- benzisothiazol-3(2H)-one, C(M)IT/MIT (3:1), 2-methylisothiazol-3(2H)-one, IPBC (risk of skin sensitisation), Bronopol (INN). EU/VOC limit for this product (Cat A/g) is 30g/L. This product contains max 30g/L VOC.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
